Maddy L. Bolger

FDA Releases Final Guidance On Best Practices For Bioresearch Monitoring Inspections

FDA Presses Forward On Patient-Focused Drug Development, Releases Final Guidance Focused On Fit-For-Purpose Clinical Outcome Assessments

FDA's New Communications And Compliance Tool For Device Data Integrity Concerns

FDA Debuts A New Communications And Compliance Tool For Device Data Integrity Concerns

FDA Publishes A Wide Range Of Guidances In The Final Days Of The Biden Administration

FDA Announces New Center For Real-World Evidence Innovation